JP2016503397A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016503397A5 JP2016503397A5 JP2015539720A JP2015539720A JP2016503397A5 JP 2016503397 A5 JP2016503397 A5 JP 2016503397A5 JP 2015539720 A JP2015539720 A JP 2015539720A JP 2015539720 A JP2015539720 A JP 2015539720A JP 2016503397 A5 JP2016503397 A5 JP 2016503397A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- agent
- composition
- heart failure
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261716867P | 2012-10-22 | 2012-10-22 | |
| US61/716,867 | 2012-10-22 | ||
| US201361822752P | 2013-05-13 | 2013-05-13 | |
| US61/822,752 | 2013-05-13 | ||
| US201361839750P | 2013-06-26 | 2013-06-26 | |
| US201361839743P | 2013-06-26 | 2013-06-26 | |
| US61/839,743 | 2013-06-26 | ||
| US61/839,750 | 2013-06-26 | ||
| PCT/US2013/066228 WO2014066419A2 (en) | 2012-10-22 | 2013-10-22 | Methods for reducing risks associated with heart failure and factors associated therewith |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018018942A Division JP2018109012A (ja) | 2012-10-22 | 2018-02-06 | 心不全関連リスクおよびそれらと関連する因子を減少させる方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016503397A JP2016503397A (ja) | 2016-02-04 |
| JP2016503397A5 true JP2016503397A5 (https=) | 2016-12-08 |
Family
ID=50545459
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015539720A Pending JP2016503397A (ja) | 2012-10-22 | 2013-10-22 | 心不全関連リスクおよびそれらと関連する因子を減少させる方法 |
| JP2018018942A Pending JP2018109012A (ja) | 2012-10-22 | 2018-02-06 | 心不全関連リスクおよびそれらと関連する因子を減少させる方法 |
| JP2019104270A Pending JP2019194193A (ja) | 2012-10-22 | 2019-06-04 | 心不全関連リスクおよびそれらと関連する因子を減少させる方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018018942A Pending JP2018109012A (ja) | 2012-10-22 | 2018-02-06 | 心不全関連リスクおよびそれらと関連する因子を減少させる方法 |
| JP2019104270A Pending JP2019194193A (ja) | 2012-10-22 | 2019-06-04 | 心不全関連リスクおよびそれらと関連する因子を減少させる方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20150246092A1 (https=) |
| EP (5) | EP2908839B1 (https=) |
| JP (3) | JP2016503397A (https=) |
| KR (1) | KR20160009008A (https=) |
| CN (2) | CN105050613A (https=) |
| AU (2) | AU2013334788A1 (https=) |
| BR (1) | BR112015009072A2 (https=) |
| CA (1) | CA2889155A1 (https=) |
| ES (1) | ES3058737T3 (https=) |
| MX (1) | MX2015005102A (https=) |
| NI (1) | NI201500057A (https=) |
| PE (1) | PE20151434A1 (https=) |
| WO (1) | WO2014066419A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3626252A1 (en) | 2013-03-01 | 2020-03-25 | Stealth Biotherapeutics Corp | Methods and compositions for the prevention or treatment of barth syndrome |
| CN110339339A (zh) | 2013-03-01 | 2019-10-18 | 康德生物医疗技术公司 | 治疗线粒体疾病的方法 |
| US10047395B2 (en) * | 2013-06-26 | 2018-08-14 | Stealth Biotherapeutics Corp | Methods and compositions for detecting and diagnosing diseases and conditions |
| CA3020393A1 (en) | 2016-04-11 | 2017-10-19 | Carnot, Llc | Chiral peptides |
| WO2017223533A1 (en) * | 2016-06-24 | 2017-12-28 | University Of Southern California | Mentsh analogs as therapeutics for diabetes, obesity, and their associated diseases and complications |
| KR20200012823A (ko) * | 2017-02-01 | 2020-02-05 | 예일 유니버시티 | 이뇨제 내성의 치료 |
| CA3087699A1 (en) | 2018-01-05 | 2019-07-11 | Corvidia Therapeutics, Inc. | Methods for treating il-6 mediated inflammation without immunosuppression |
| KR102546547B1 (ko) | 2018-01-11 | 2023-06-22 | 삼성전자주식회사 | 보행 보조 방법 및 장치 |
| KR20220052561A (ko) | 2020-10-21 | 2022-04-28 | 장영진 | 어류 가공물 및/또는 콩 가공물을 유효성분으로 포함하는 심부전의 예방 또는 치료용 약학 조성물 |
| CN120329388B (zh) * | 2025-04-30 | 2025-09-26 | 中日友好医院(中日友好临床医学研究所) | 一种双靶点多肽及其在心衰治疗中的应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| US20040219142A1 (en) * | 2002-07-19 | 2004-11-04 | Abbott Laboratories S.A. | Treatment of skin and nail disorders using TNFalpha inhibitors |
| SI2656854T1 (sl) * | 2003-02-04 | 2015-09-30 | Cornell Research Foundation, Inc. | Uporabe aromatsko-kationskega peptida |
| EP1890153A1 (en) * | 2006-08-16 | 2008-02-20 | F. Hoffman-la Roche AG | Cardiac troponin as an indicator of advanced coronary artery disease |
| EP1890154B1 (en) * | 2006-08-16 | 2012-07-04 | F. Hoffmann-La Roche AG | Cardiac troponin as an indicator of advanced coronary artery disease |
| US20080318909A1 (en) * | 2007-06-14 | 2008-12-25 | Sparagna Genevieve C | Use Of Linoleic Compounds Against Heart Failure |
| DK2262520T3 (en) * | 2008-02-26 | 2017-08-07 | Univ Cornell | COMPOSITIONS FOR PREVENTION AND TREATMENT OF Kidney Injury |
| CN105031605A (zh) * | 2009-08-12 | 2015-11-11 | 康奈尔大学 | 预防或治疗代谢综合症的方法 |
| EP2485749A4 (en) * | 2009-10-05 | 2013-07-24 | Univ Cornell | METHOD FOR THE PREVENTION AND TREATMENT OF HEART FAILURE |
| WO2011066374A2 (en) * | 2009-11-24 | 2011-06-03 | Alder Biopharmaceuticals, Inc. | Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| CN103751763A (zh) * | 2009-12-31 | 2014-04-30 | 康肽德生物医药技术有限公司 | 用于预防或治疗血管阻塞损伤的方法 |
| EP3266462A1 (en) * | 2009-12-31 | 2018-01-10 | Stealth Peptides International, Inc. | Methods for performing a coronary artery bypass graft procedure |
| EP3332795A1 (en) * | 2010-02-26 | 2018-06-13 | Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") | Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy |
| EP3375449A1 (en) * | 2010-03-15 | 2018-09-19 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
| HK1210953A1 (en) * | 2012-08-02 | 2016-05-13 | Stealth Peptides International, Inc. | Methods for treatment of atherosclerosis |
| EP2928562A4 (en) * | 2012-12-06 | 2016-06-22 | Stealth Peptides Int Inc | PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE |
| WO2014210062A1 (en) * | 2013-06-26 | 2014-12-31 | Stealth Peptides International, Inc. | Methods for the regulation of matrix metalloproteinase expression |
| US10047395B2 (en) * | 2013-06-26 | 2018-08-14 | Stealth Biotherapeutics Corp | Methods and compositions for detecting and diagnosing diseases and conditions |
-
2013
- 2013-10-22 AU AU2013334788A patent/AU2013334788A1/en not_active Abandoned
- 2013-10-22 WO PCT/US2013/066228 patent/WO2014066419A2/en not_active Ceased
- 2013-10-22 EP EP13849406.7A patent/EP2908839B1/en active Active
- 2013-10-22 CN CN201380067076.XA patent/CN105050613A/zh active Pending
- 2013-10-22 MX MX2015005102A patent/MX2015005102A/es unknown
- 2013-10-22 JP JP2015539720A patent/JP2016503397A/ja active Pending
- 2013-10-22 KR KR1020157013559A patent/KR20160009008A/ko not_active Ceased
- 2013-10-22 EP EP21197102.3A patent/EP4005582A1/en not_active Withdrawn
- 2013-10-22 EP EP25219700.9A patent/EP4711005A3/en active Pending
- 2013-10-22 EP EP24159638.6A patent/EP4397314B1/en active Active
- 2013-10-22 CN CN201910384895.6A patent/CN110193077A/zh active Pending
- 2013-10-22 US US14/437,325 patent/US20150246092A1/en not_active Abandoned
- 2013-10-22 PE PE2015000538A patent/PE20151434A1/es not_active Application Discontinuation
- 2013-10-22 ES ES24159638T patent/ES3058737T3/es active Active
- 2013-10-22 EP EP19185584.0A patent/EP3586862B1/en active Active
- 2013-10-22 BR BR112015009072A patent/BR112015009072A2/pt not_active IP Right Cessation
- 2013-10-22 CA CA2889155A patent/CA2889155A1/en not_active Abandoned
-
2015
- 2015-04-22 NI NI201500057A patent/NI201500057A/es unknown
-
2018
- 2018-02-06 JP JP2018018942A patent/JP2018109012A/ja active Pending
- 2018-07-19 AU AU2018206766A patent/AU2018206766A1/en not_active Abandoned
-
2019
- 2019-06-04 JP JP2019104270A patent/JP2019194193A/ja active Pending
- 2019-12-20 US US16/724,076 patent/US20200360462A1/en not_active Abandoned
-
2022
- 2022-06-13 US US17/838,766 patent/US20230190859A1/en not_active Abandoned
-
2025
- 2025-01-16 US US19/025,542 patent/US20250255929A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503397A5 (https=) | ||
| Angeli et al. | Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide | |
| Selman et al. | Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches | |
| Dagher et al. | The hepatorenal syndrome | |
| Browne et al. | Pathophysiology of pulmonary complications of acute pancreatitis | |
| Sezai et al. | Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study | |
| Momma | ACE inhibitors in pediatric patients with heart failure | |
| Ahmadi et al. | Thyroid gland dysfunction and its effect on the cardiovascular system: a comprehensive review of the literature | |
| CN103429236B (zh) | 治疗高尿酸血症和与高尿酸血症相关的代谢性病症的方法和组合物 | |
| JP2016522196A5 (https=) | ||
| JP2013506696A5 (https=) | ||
| JP2022137224A (ja) | 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ | |
| JP2016511259A5 (https=) | ||
| Kitakaze et al. | levation of Plasma Adenosine Levels May Attenuate the Severity of Chronic Heart Failure | |
| JP2005515214A5 (https=) | ||
| Xu et al. | Protective role of AT2 and B1 receptors in kinin B2-receptor-knockout mice with myocardial infarction | |
| van der Jagt et al. | Beta-blockers in intensive care medicine: potential benefit in acute brain injury and acute respiratory distress syndrome | |
| Ye et al. | Inhibition of the P2X7 receptor prevents atrial proarrhythmic remodeling in experimental post-operative atrial fibrillation | |
| McBride et al. | Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management | |
| Rosseel et al. | Postcardiac surgery low cardiac output syndrome: dopexamine or dopamine? | |
| WO2023183339A1 (en) | Selective vasopressin receptor agonist for end-stage liver disease | |
| Morganti et al. | Aliskiren: the first direct renin inhibitor available for clinical use | |
| JP2021530517A5 (https=) | ||
| AU4079001A (en) | Composition for the treatment of heart failure | |
| JP2008515903A5 (https=) |